Home

Myomo Inc. Common Stock (MYO)

3.2000
-0.1600 (-4.76%)
NYSE · Last Trade: May 11th, 5:00 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close3.360
Open3.370
Bid3.200
Ask3.400
Day's Range3.160 - 3.470
52 Week Range2.760 - 7.170
Volume1,130,564
Market Cap66.95M
PE Ratio (TTM)-22.86
EPS (TTM)-0.1
Dividend & YieldN/A (N/A)
1 Month Average Volume466,245

Chart

About Myomo Inc. Common Stock (MYO)

Myomo Inc is a medical technology company focused on developing and providing advanced robotic solutions to assist individuals with neuromuscular disorders and mobility impairments. Their flagship product is an innovative wearable device designed to restore arm and hand function for patients who have experienced conditions such as stroke or spinal cord injury. By leveraging cutting-edge technology and research, Myomo aims to improve the quality of life for its users, enabling greater independence and engagement in daily activities. The company is dedicated to enhancing rehabilitation outcomes through its unique approach to personalized therapy solutions. Read More

News & Press Releases

Top movers analysis one hour before the close of the markets on 2025-05-08: top gainers and losers in today's session.chartmill.com
Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · May 8, 2025
What's going on in today's sessionchartmill.com
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top gainers and losers in today's session.
Via Chartmill · May 8, 2025
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · May 8, 2025
Earnings Scheduled For May 7, 2025benzinga.com
Via Benzinga · May 7, 2025
A Glimpse of Myomo's Earnings Potentialbenzinga.com
Via Benzinga · May 6, 2025
Get insights into the top gainers and losers of Wednesday's after-hours session.chartmill.com
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · May 7, 2025
Myomo Reports First Quarter 2025 Financial and Operating Results
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2025.
By Myomo, Inc. · Via Business Wire · May 7, 2025
Myomo to Host Investor & Analyst Day Event on June 18, 2025
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces the Company will be hosting its first-ever Investor & Analyst Day event on Wednesday, June 18, 2025. The event will take place at Myomo’s new corporate headquarters and manufacturing facility in Burlington, Mass., and will offer an in-depth look at the Company’s latest innovations, strategic plans and growth initiatives to empower individuals with neuromuscular disorders through cutting-edge wearable medical robotics.
By Myomo, Inc. · Via Business Wire · May 1, 2025
Myomo to Report First Quarter 2025 Financial Results on May 7
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2025 on May 7, 2025.
By Myomo, Inc. · Via Business Wire · April 30, 2025
Myomo Launches the MyoPro® 2x
Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers improved arm and hand function for individuals with upper-limb paralysis and neuromuscular conditions, today announced the launch of the MyoPro 2x, the latest evolution in its flagship MyoPro product line.
By Myomo, Inc. · Via Business Wire · April 30, 2025
Myomo Announces Upcoming Changes to its Board of Directors
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that directors Amy Knapp and Yitzchak Jacobovitz have informed the board they will not stand for re-election as Class II directors. Ms. Knapp has been a director since July 2016 and Mr. Jacobovitz has served on Myomo’s board since January 2023. Their terms will conclude as of the Company’s 2025 Annual Meeting expected to be held in June 2025.
By Myomo, Inc. · Via Business Wire · April 10, 2025
Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer and David Henry, chief financial officer, will present at the 24th Annual Needham Virtual Healthcare Conference, being held from April 7th to April 10th, and will be holding one-on-one meetings with investors registered with the conference. The presentation will be webcast live at 3:00 p.m. ET on Thursday April 10th. The presentation will also be archived in the Investors section of the Company’s website.
By Myomo, Inc. · Via Business Wire · March 31, 2025
Tuesday's session: top gainers and loserschartmill.com
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · March 11, 2025
Gapping stocks in Tuesday's sessionchartmill.com
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · March 11, 2025
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · March 11, 2025
What's going on in today's after hours sessionchartmill.com
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · March 10, 2025
Myomo's Fourth Quarter Financial Results Feature Record Revenue of $12.1 Million
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months and year ended December 31, 2024.
By Myomo, Inc. · Via Business Wire · March 10, 2025
Earnings Scheduled For March 10, 2025benzinga.com
Via Benzinga · March 10, 2025
Myomo to Report Fourth Quarter 2024 Financial Results on March 10
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the fourth quarter and year ended December 31, 2024 on March 10, 2025.
By Myomo, Inc. · Via Business Wire · March 3, 2025
3 Underrated Robotics Stocks Poised for Major Growth
Robotics firms that may deserve a closer look by investors include AeroVironment, Cognex, and Myomo, all of which offer compelling products and tech.
Via MarketBeat · February 3, 2025
Top 3 Cutting-Edge Micro-Caps Set for 2025 Growth
These three high-tech micro-cap stocks have made solid business progress in 2024, warranting them to be on investors radars in 2025.
Via MarketBeat · December 17, 2024
Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock
Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has priced an underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $5.00 per share. Myomo expects the gross proceeds from this offering to be approximately $15.0 million, before deducting the underwriting discount and other offering expenses. In connection with the offering, Myomo has granted the underwriter a 30-day option to purchase up to 450,000 additional shares of its common stock at the public offering price, less the underwriting discount. Myomo expects to close the offering, subject to the satisfaction of customary conditions, on or about December 6, 2024.
By Myomo, Inc. · Via Business Wire · December 5, 2024
Myomo, Inc. Announces Proposed Public Offering of Common Stock
Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. In connection with the offering, Myomo also expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
By Myomo, Inc. · Via Business Wire · December 4, 2024
Nvidia To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesdaybenzinga.com
Via Benzinga · November 12, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · November 7, 2024